Pembrolizumab,Vibostolimab,Favezelimab
Merck
['mibc', 'pembro', 'key,note,52', 'key,note,57', ' cis ', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
pembrolizumab monotherapy for pts with high-risk #nmibc unresponsive to bcg: results from cohort b of the phase 2 #keynote057 trial. presented by michiel van der heijden, md, phd . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology